cyclophosphamide / Generic mfg.  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

   Remove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclophosphamide / Generic mfg.
GAZELLE, NCT03817853: An Open-Label, Single Arm Study of Obinutuzumab Short Duration Infusion in Patients With Previously Untreated Advanced Follicular Lymphoma

Completed
4
114
Europe, Japan, US, RoW
Obinutuzumab, GA101, RO5072759, Bendamustine, Cyclophosphamide, Doxorubicin, Prednisone/Prednisolone/Methylprednisolone, Vincristine
Hoffmann-La Roche
Advanced Follicular Lymphoma
08/20
01/23
RAPID, NCT05421897: Rapid Administration Pilot for Infusing Dinutuximab

Recruiting
4
11
US
Dinutuximab with Chemotherapy, Cyclophosphamide, Topotecan, Temozolomide, Irinotecan, Sagramostim
Children's Hospital Los Angeles, United Therapeutics
Neuroblastoma
08/24
08/24

Download Options